1375301-91-9 Usage
Uses
Used in Organic Synthesis:
2-cyclopropyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine is used as a reagent in organic synthesis for its ability to participate in a variety of chemical reactions, including cross-coupling and other boron-mediated processes. Its unique boron-containing group facilitates the formation of new carbon-carbon or carbon-heteroatom bonds, which are crucial in the construction of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-cyclopropyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine is used as a building block for the creation of novel drug candidates. Its incorporation into molecular frameworks can lead to the development of new therapeutic agents with potential applications in treating various diseases, given its ability to be modified and functionalized through organic synthesis.
Used in Agrochemical Production:
Similarly, in agrochemicals, 2-cyclopropyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine is utilized as a key intermediate in the synthesis of new pesticides, herbicides, or other crop protection agents. Its unique structure and reactivity can contribute to the design of more effective and targeted agrochemicals.
Further research and testing are essential to fully explore the properties and potential applications of 2-cyclopropyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine across different fields, ensuring its safe and effective use in creating innovative materials and compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1375301-91-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,3,0 and 1 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1375301-91:
(9*1)+(8*3)+(7*7)+(6*5)+(5*3)+(4*0)+(3*1)+(2*9)+(1*1)=149
149 % 10 = 9
So 1375301-91-9 is a valid CAS Registry Number.
1375301-91-9Relevant academic research and scientific papers
ASK1 INHIBITOR COMPOUNDS AND USES THEREOF
-
Paragraph 0427; 0429, (2018/11/02)
Described herein are compounds, including pharmaceutically acceptable salts, solvates, metabolites, prodrugs thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat non
